CFTR and cystic fibrosis: Therapy of CF was revolutionised with the implementation of CFTR modulators by directly addressing these molecular defects, showing particular efficacy for class II (misfolding) and III (chloride channel gating) variants (Ensinck and Carlon, 2022).